142
Participants
Start Date
October 5, 2021
Primary Completion Date
December 19, 2023
Study Completion Date
November 30, 2027
ISL
Capsules administered orally without regard to food
LEN
Tablets administered orally without regard to food
B/F/TAF
Tablets administered orally without regard to food
ISL/LEN FDC
Tablets administered orally without regard to food
Jacobi Medical Center, The Bronx
New York-Presbyterian Queens, Flushing
Penn Medicine: Perelman Center for Advanced Medicine at the Hospital of the University of Pennsylvania, Philadelphia
Philadelphia FIGHT Community Health Centers, Philadelphia
Washington Health Institute, Washington D.C.
The George Washington University Medical Faculty Associates Inc., Washington D.C.
NC TraCS Institute - CTRC: University of North Carolina at Chapel Hill, Chapel Hill
Metro Infectious Disease Consultants, Decatur
Emory University Hospital Midtown Infectious Disease Clinic, Atlanta
Atlanta ID Group, PC, Atlanta
Chatham County Health Department, Savannah
Orlando Immunology Center, Orlando
Floridian Clinical Research, Miami Lakes
Schiff Center for Liver Diseases/University of Miami, Miami
CAN Community Health Care, Inc., Fort Lauderdale
JEM Research Institute, Lake Worth
Midway Immunology and Research Center, Ft. Pierce
Indiana CTSI Clinical Research Center, Indianapolis
Be Well Medical Center, Berkley
Hennepin Healthcare HCMC, New Brighton
Howard Brown Health Center, Chicago
Northstar Healthcare, Chicago
Southampton Healthcare, Inc., St Louis
AIDS Arms Inc, Dallas
North Texas Infectious Diseases Consultants, P.A., Dallas
The Crofoot Research Center, INC, Houston
Central Texas Clinical Research, LLC, Austin
Public Health Institute at Denver Health, Denver
Vivent Health, Denver
AXCES Research Group, Santa Fe
Huntridge Family Clinic, Las Vegas
Ruane Clinical Research Group, Inc, Los Angeles
Mills Clinical Research, Los Angeles
Pacific Oaks Medical Group, Beverly Hills
BIOS Clinical Research, Palm Springs
Hoag Medical Group - Newport Beach, Newport Beach
Optimus Medical Group, San Francisco
John A. Burns School of Medicine, University of Hawaii Clinics at Kaka'ako, Honolulu
Peter Shalit, M.D., Seattle
Community Health Care, Tacoma
MultiCare Rockwood Main Clinic, Spokane
Boston Medical Center, Boston
AccessHealth MA, Boston
ID Care, Hillsborough
Lead Sponsor
Merck Sharp & Dohme LLC
INDUSTRY
Gilead Sciences
INDUSTRY